Search results for "PROGNOSIS"

showing 10 items of 2052 documents

Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain.

2006

Little is known about the prognostic value of leukocyte count on admission for patients with chest pain. In total, 1,461 patients who presented to the emergency department with non–ST-segment elevation chest pain were studied by clinical history, electrocardiography, serial troponin I determination, and leukocyte count on admission. End points were 1-year mortality and major events (mortality or infarction). Overall patient distribution by quartiles of leukocyte count showed increased mortality (6%, 7%, 6%, and 17%, p = 0.0001) and major events (13%, 13%, 15%, and 24%, p = 0.0001) in the fourth quartile. After adjustment for other risk factors, the fourth quartile cut-off value (>10,000 cel…

AdultMalemedicine.medical_specialtyChest PainMyocardial InfarctionChest painElectrocardiographyLeukocyte CountPatient AdmissionWhite blood cellInternal medicineTroponin IOutcome Assessment Health CareDiabetes MellitusMedicineST segmentHumansMyocardial infarctionAgedST depressionAged 80 and overbusiness.industryST elevationHazard ratioTroponin IAge FactorsMiddle Agedmedicine.diseasePrognosismedicine.anatomical_structureSpainMultivariate AnalysisCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalFollow-Up StudiesThe American journal of cardiology
researchProduct

Primary pulmonary sarcomas: Etiology, clinical assessment and prognosis with a comparison to pulmonary carcinomas —A review of 41 cases and 394 other…

1982

Primary sarcomas of the lungs occur at frequencies of 1:100, as compared with carcinomas reported in our retrospective studies covering 394 cases reported in the literature from 1957 to 1972 and 41 cases from 1957 to 1974. The average age was 45 years, the disease usually occurred between the ages of 35 and 65, the peak being between 45 and 60 years. Distribution between sexes was much the same as that seen in general. X-ray with rapid thoracotomy provided the best clinical results. The literature showed a postoperative survival time of 5 years in 19% and 44% of our own cases. The general metastasis, haematologenous and lymphogenous were more or less equal and recidive tendency in 7% essent…

AdultMalemedicine.medical_specialtyChronic bronchitisPathologyLung NeoplasmsAdolescentmedicine.medical_treatmentGastroenterologyMetastasisJapanInternal medicinemedicineCarcinomaHumansThoracotomyChildAgedbusiness.industryIncidence (epidemiology)CarcinomaSmokingAge FactorsInfantSarcomaRetrospective cohort studyGeneral MedicineMiddle AgedPrognosismedicine.diseaseChild PreschoolEtiologyFemaleSurgerySarcomabusinessThe Japanese Journal of Surgery
researchProduct

Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer.

2013

To characterize the stage-specific prognostic relevance of preoperative systemic inflammatory response, defined by C-reactive protein (CRP), in colon cancer (CC) patients.Data from CC patients operated on from 1998 to 2007 at three hospitals from three different Nordic countries were collected retrospectively from national registries, local databases and/or patient records. Patients with emergency surgery, infection or auto-immune disease were excluded. Associations between clinical or histopathological variables and CRP were assessed. Patients were followed from the date of surgery to death or end of follow-up. Disease-specific survival (DSS) was the main endpoint.In total, 525 patients wi…

AdultMalemedicine.medical_specialtyColorectal cancerIncreased C-reactive proteinDiseaseGastroenterologyInternal medicinemedicineBiomarkers TumorHumansRadiology Nuclear Medicine and imagingStage (cooking)Stage specificSurvival rateAgedNeoplasm StagingRetrospective StudiesAged 80 and overbusiness.industryElevated crpRetrospective cohort studyHematologyGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurgerySurvival RateC-Reactive ProteinOncologyLymphatic MetastasisColonic NeoplasmsFemaleNeoplasm GradingbusinessFollow-Up StudiesActa oncologica (Stockholm, Sweden)
researchProduct

Modified Wong's Classification Improves the Accuracy of Rectal Cancer Staging by Endorectal Ultrasound and MRI

2013

BACKGROUND: Douglas Wong proposed a new classification of tumor penetration in the rectal wall (T stage) in an attempt to incorporate the prognostic heterogeneity of T3 rectal cancers into the preoperative staging. OBJECTIVE: This study aimed to evaluate if the accuracy of endorectal ultrasound and MRI in predicting rectal cancer T staging improves when using a modified Wong's classification. DESIGN: This prospective series compares local standard TN staging and a modified Wong's classification. SETTINGS: This study was conducted by a specialized Colorectal Multidisciplinary Team at a tertiary teaching hospital. PATIENTS: Seventy patients underwent surgery for middle or low rectal cancer be…

AdultMalemedicine.medical_specialtyColorectal cancerPathological stagingEndosonographyEndorectal ultrasoundmedicineCarcinomaHumansProspective StudiesStage (cooking)Prospective cohort studyAgedNeoplasm StagingAged 80 and overmedicine.diagnostic_testRectal Neoplasmsbusiness.industryCarcinomaGastroenterologyMagnetic resonance imagingGeneral MedicineMiddle AgedPrognosismedicine.diseaseMagnetic Resonance ImagingT-stageFemaleRadiologybusinessDiseases of the Colon & Rectum
researchProduct

Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohn's Disease: A Prospective Observational Study.

2013

International audience; BACKGROUND:: Patients with Crohn's disease (CD) of the colon are at risk for colorectal cancer and should be screened for dysplasia and cancer of the colon. Small bowel adenocarcinoma (SBA) is a complication of small bowel CD and carries a poor prognosis. However, there is no screening test for SBA in patients with small bowel CD. The aim of this study was to assess the risk and incidence of SBA in a large prospective cohort of patients with small bowel CD and to compare it with the risk of colorectal cancer in patients with CD involving the colon, recruited in the same cohort. METHODS:: In a nationwide French cohort, 11,759 patients with CD were enrolled by 680 gast…

AdultMalemedicine.medical_specialtyColorectal cancerPopulationAdenocarcinomaGastroenterology03 medical and health sciences0302 clinical medicineCrohn DiseaseInterquartile rangeRisk Factors[ CHIM.ORGA ] Chemical Sciences/Organic chemistryInternal medicinemedicineImmunology and AllergyHumansProspective StudieseducationProspective cohort studyCrohn's diseaseeducation.field_of_studybusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryIncidence (epidemiology)IncidenceGastroenterologyCancerMiddle Agedmedicine.diseasePrognosisdigestive system diseasesIleal Neoplasms030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyFemaleFrancebusinessColorectal NeoplasmsFollow-Up Studies
researchProduct

Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation…

2017

Abstract Background Adjuvant chemotherapy is controversial in patients with locally advanced rectal cancer after preoperative chemoradiation. Valentini et al developed 3 nomograms (VN) to predict outcomes in these patients. The neoadjuvant rectal score (NAR) was developed after VN to predict survival. We aimed to validate these tools in a retrospective cohort at an academic institution. Patients and Methods VN and the NAR were applied to 158 consecutive patients with locally advanced rectal cancer treated with chemoradiation followed by surgery. According to the score, they were divided into low, intermediate, or high risk of relapse or death. For statistical analysis, we performed Kaplan-M…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentRectal neoplasms prognosisLocally advancedUrologyKaplan-Meier EstimateRisk AssessmentAdjuvant; Chemotherapy; Rectal neoplasms prognosis; Oncology; GastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicinemedicineChemotherapyHumans030212 general & internal medicineAdjuvantSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overChemotherapyRectal NeoplasmsProportional hazards modelbusiness.industryHazard ratioGastroenterologyRetrospective cohort studyChemoradiotherapy AdjuvantMiddle AgedNomogrammedicine.diseaseNeoadjuvant TherapySurgeryNomogramsTreatment OutcomeOncology030220 oncology & carcinogenesisFemaleRisk assessmentbusinessClinical Colorectal Cancer
researchProduct

Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Soreze 2009

2010

Background: Inherited ichthyoses belong to a large, clinically and etiologically heterogeneous group of mendelian disorders of cornification; typically involving the entire integument. Over the recent years, much progress has been made defining their molecular causes. However, there is no internationally accepted classification and terminology. Objective: We sought to establish a consensus for the nomenclature and classification of inherited ichthyoses. Methods: The classification project started at the First World Conference on Ichthyosis in 2007. A large international network of expert clinicians, skin pathologists, and geneticists entertained an interactive dialogue over 2 years, eventua…

AdultMalemedicine.medical_specialtyCongenital ichthyosiform erythrodermaAdolescentautosomal recessive congenital ichthyosisDermatologySeverity of Illness Indexhistologymendelian disorders of cornificationYoung AdultCYP4F22Terminology as TopicCongenital ichthyosisMedicineHumansGenetic Predisposition to DiseasegeneticsABCA12Childbiologybusiness.industryIchthyosisInfant NewbornIchthyosisInfantkeratinopathic ichthyosisLamellar ichthyosisHarlequin IchthyosisCongresses as TopicIchthyosiform Erythroderma Congenitalepidermolytic ichthyosismedicine.diseasePrognosisDermatologyultrastructureGene Expression RegulationPractice Guidelines as Topicbiology.proteinFemaleDermatologic AgentsFrancesuperficial epidermolytic ichthyosisbusinessIchthyosis vulgarisJournal of the American Academy of Dermatology
researchProduct

Type I Diabetes is the Main Cost Driver in Autoimmune Polyendocrinopathy

2019

Abstract Context Autoimmune polyendocrinopathy (AP), a chronic complex orphan disease, encompasses at least two autoimmune-induced endocrine diseases. Objective To estimate for the first time total, indirect and direct costs for patients with AP, as well as cost drivers. Design Cross-sectional cost of illness study. Setting Academic tertiary referral center for AP. Patients 146 consecutive, unselected AP patients. Intervention Interviews pertaining to patients’ socioeconomic situation covered a recall period of 12 months. Both the human capital (HCA) and the friction cost approaches (FCAs) were applied as estimation methods. Main outcome measures Direct and indirect annual costs, and sick l…

AdultMalemedicine.medical_specialtyCost estimateEndocrinology Diabetes and MetabolismClinical BiochemistryContext (language use)DiseaseBiochemistryYoung AdultIndirect costsEndocrinologyCost of IllnessInternal medicinemedicineHumansPolyendocrinopathies AutoimmuneAgedType 1 diabetesbusiness.industryBiochemistry (medical)Health Care CostsAutoimmune polyendocrinopathyMiddle AgedPrognosismedicine.diseaseCross-Sectional StudiesDiabetes Mellitus Type 1EndocrinologyCost driverSick leaveFemalebusinessFollow-Up StudiesThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data.

2020

Abstract Purpose The aim of this study is to present the treatment modalities and associated side effects in a Polish nation-wide ANCA-associated vasculitides (AAV) patients’ cohort. Materials and methods Retrospective analysis of patients diagnosed with AAV between 1990 and 2016, included in the POLVAS registry was performed. Standard descriptive statistic methods were used with an emphasis on the treatment modalities. Results There were 625 patients diagnosed with AAV included in this study: 417 cases of granulomatosis with polyangiitis (GPA; 66.7%), 106 cases of microscopic polyangiitis (MPA; 17.0%) and 102 cases of eosinophilic granulomatosis with polyangiitis (EGPA; 16.3%). The mean ag…

AdultMalemedicine.medical_specialtyCyclophosphamideDrug-Related Side Effects and Adverse ReactionsAzathioprineAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis03 medical and health sciences0302 clinical medicineMaintenance therapyInternal medicineAzathioprinemedicineHumansTreatment complications030212 general & internal medicineRegistriesAdverse effectCyclophosphamideGlucocorticoidsANCA associated vasculitisRetrospective Studiesbusiness.industryVasculitis registryGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurvival RateMethotrexate030220 oncology & carcinogenesisCohortRituximabDrug Therapy CombinationFemalePolandMicroscopic polyangiitisGranulomatosis with polyangiitisbusinessRituximabVasculitis treatmentImmunosuppressive Agentsmedicine.drugFollow-Up StudiesAdvances in medical sciences
researchProduct

Hereditary angioedema with normal C1-INH withversuswithout specificF12gene mutations

2015

Background Hereditary angioedema with normal C1-INH may be linked to specific mutations in the coagulation factor 12 (FXII) gene (HAE-FXII) or mutations in genes that are still unknown (HAE-unknown). To assess the differences in transmission and inheritance, clinical features, and laboratory parameters between patients with HAE-FXII and HAE-unknown. Methods Sixty-nine patients with HAE-FXII from 23 unrelated families and 196 patients with HAE-unknown from 65 unrelated families were studied. Results Both HAE-FXII and HAE-unknown are inherited as autosomal-dominant traits with incomplete penetrance. The male to female ratio was 1 : 68 in HAE-FXII and 1 : 6.3 in HAE-unknown. The maternal to pa…

AdultMalemedicine.medical_specialtyDatabases FactualOffspringImmunologyGene mutationSeverity of Illness IndexCohort StudiesYoung Adultchemistry.chemical_compoundAge DistributionInternal medicineHumansImmunology and AllergyMedicineHereditary Angioedema Type IIIAge of OnsetSex DistributionRetrospective Studiesmedicine.diagnostic_testAngioedemabusiness.industryIncidenceAngioedemas HereditaryMiddle AgedPrognosismedicine.diseasePenetranceRecombinant ProteinsPedigreePhenotypeEndocrinologychemistryPlasminogen activator inhibitor-1Factor XIIMutationHereditary angioedemaFemalemedicine.symptombusinessComplement C1 Inhibitor ProteinPartial thromboplastin timeAllergy
researchProduct